Clinical Trials
Metropolitan Dermatology’s Clinical Research Department has been established to facilitate advancement in dermatological science and improve the quality of life for our patients.
Our highly credentialed clinical research team proudly participates in development of dermatologic drugs, technology, and other treatments through FDA-supervised clinical trials.
We recommend regularly visiting our Clinical Research webpage to stay updated on the availability of new clinical trials.
Learn More About our Clinical Trials
To learn more about our Clinical Trials, please reach our Research Department at (908) 241-3181, ext. 1099 or complete the form here.
We are here to answer any questions and will reply promptly.
If you are qualified, our staff will monitor your health throughout the study. You will also receive, at no cost:
- All study-related medicines
- All study-related care and check-ins
- Access to specialized doctors and researchers
- Health insurance is not required
Current and Upcoming Clinical Trials:
Moderate-to-Severe Plaque Psoriasis
Moderate-to-Severe Atopic Dermatitis (Eczema)
Current Trial Details:
PSORIASIS: Patients who enroll will be asked to participate for about 7 months including screening, treatment, and follow-up. Participants will be compensated for time spent and reimbursed for travel expenses.
To qualify, you should be:
- Male or female 18 to 75 years of age
- Diagnosed with moderate-to-severe chronic plaque psoriasis for at least 6 months duration
- Able to swallow drug
- Participants must pass all screening assessments/procedures to be eligible for enrollment
- Additional enrollment criteria may apply
ATOPIC DERMATITIS: Patients who enroll will be asked to participate for about 12 months including screening, treatment, and follow-up. Participants will be compensated for time spent and reimbursed for travel expenses.
To qualify, you should be:
- Male or female 18 to 70 years of age
- Diagnosed with moderate-to-severe (10% or more of the skin of the body) atopic dermatitis for at least 1 year
- Candidates for systemic therapy who have failed on moderate to high potency topical corticosteroid for at least 4 weeks, or cannot use topical medications for some reason
- Patients who have not previously received any biologic therapy administered by injection (i.e., Adbry, Dupixent) or orally (i.e., Cibinquo, Rinvoq)
- Patients willing to receive the study-related medication via injection
- Participants must pass all screening assessments/procedures to be eligible for enrollment
- Additional enrollment criteria may apply
Current Registry Study Opportunities:
A registry study is a type of observational research that uses data from a registry to collect valuable information that will help advance our understanding of ideal treatment protocols for a given skin disorder. The main purpose of registry studies is to collect data to better understand long-term trends in specific populations. Our registry studies are designed to take place simultaneously with regular follow-up visits for patients already in treatment, ensuring convenience and ease for participants.
Contact our Research Department today and become an essential part of helping us develop more
effective treatment and improve patient outcomes.
